How would you approach the decision to escalate DMT in a patient with relapsing multiple sclerosis who has two to three new T2 lesion but no clinical symptoms?
In light of recent publication by Bsteh et al., PMID 39197111 that examined the outcomes in the treatment of RMS based on isolated MRI findings.
Community PollStarted
Would you escalate therapy for a patient with MS with 2-3 new T2 lesions but no clinical symptoms?
25 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Neurology · Yale University School of Medicine
Answered on
I would escalate to higher-efficacy DMT in this scenario. As highlighted in the linked article, new T2 lesions show that the patient is at heightened risk for clinical relapses and their disease activity is not well controlled. In the linked study, included patients were on low efficacy DMT (interfe...
Join for free or sign in to see the full answer